CIK 0000719135
- Non-accelerated filer
- Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112644611
- Phone
- +1 727-384-2323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Waldman Lawrence Director | Exercise or conversion | +12,000 | $1.88 | $23K | 17,338 |
| 2026-06-30 | Waldman Lawrence Director | Shares withheld for taxes | −5,024 | $4.49 | $23K | 12,314 |
| 2026-06-30 | Waldman Lawrence Director | Exercise or conversion · Stock option (right to buy) | −12,000 | 0 | ||
| 2026-06-11 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-05-15 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +30,000 | 30,000 | ||
| 2025-01-15 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2024-08-08 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2023-08-10 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2023-07-12 | Waldman Lawrence Director | Exercise or conversion | +5,338 | $2.97 | $16K | 5,338 |
| 2023-07-12 | Waldman Lawrence Director | Exercise or conversion · Stock Option (Option to Buy) | −12,000 | 0 | ||
| 2022-08-11 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-07-11 | Waldman Lawrence Director | Exercise or conversion | +24,000 | $2.54 | $61K | 37,563 |
| 2022-07-11 | Waldman Lawrence Director | Exercise or conversion · Stock Option (Option to Buy) | −24,000 | 0 | ||
| 2022-05-19 | Waldman Lawrence Director | Exercise or conversion | +8,000 | $2.79 | $22K | 13,563 |
| 2022-05-19 | Waldman Lawrence Director | Exercise or conversion · Stock Option (Option to Buy) | −8,000 | 0 | ||
| 2021-08-06 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2021-03-08 | Waldman Lawrence Director | Exercise or conversion | +5,563 | $2.81 | $16K | 5,563 |
| 2021-03-08 | Waldman Lawrence Director | Option exercise · Stock Option (Option to Buy) | −7,500 | $2.81 | $21K | 0 |
| 2019-08-01 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2018-08-30 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +24,000 | 24,000 |
Page 1 of 2 · 29 trades